Antidepressant Pretreatment for the Prevention of Interferon Alfa-Associated Depression: A Systematic Review and Meta-AnalysisSARKAR, Susanne; SCHAEFER, Martin.Psychosomatics (Washington, DC). 2014, Vol 55, Num 3, pp 221-234, issn 0033-3182, 14 p.Article

Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis CSCHAEFER, Martin; SCHWAIGER, Markus; GARKISCH, Andrea S et al.Journal of hepatology. 2005, Vol 42, Num 6, pp 793-798, issn 0168-8278, 6 p.Article

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?SCHAEFER, Martin; HEINZ, Andreas; BACKMUND, Markus et al.Addiction (Abingdon. Print). 2004, Vol 99, Num 9, pp 1167-1175, issn 0965-2140, 9 p.Article

Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα) : results from a prospective studyLIEB, Klaus; ENGELBRECHT, Marc A; GUT, Oliver et al.European psychiatry. 2006, Vol 21, Num 3, pp 204-210, issn 0924-9338, 7 p.Article

Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr vims-induced encephalitisBEHR, Joachim; SCHAEFER, Martin; LITTMANN, Eckhard et al.European psychiatry. 2006, Vol 21, Num 8, pp 521-522, issn 0924-9338, 2 p.Article

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groupsSCHAEFER, Martin; SCHMIDT, Folkhard; LOESCHKE, Klaus et al.Hepatology (Baltimore, Md.). 2003, Vol 37, Num 2, pp 443-451, issn 0270-9139, 9 p.Article

Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on designGRUNZE, Heinz C. R; NORMANN, Claus; LANGOSCH, Jens et al.The Journal of clinical psychiatry. 2001, Vol 62, Num 6, pp 464-468, issn 0160-6689Article

Management of Mental Health Problems Prior to and During Treatment of Hepatitis C Virus Infection in Patients With Drug AddictionSCHAEFER, Martin; SARKAR, Rahul; DIEZ-QUEVEDO, Crisanto et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S111-S117, SUP2Article

Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statementSCHAEFER, Martin; CAPURON, Lucile; FRIEBE, Astrid et al.Journal of hepatology. 2012, Vol 57, Num 6, pp 1379-1390, issn 0168-8278, 12 p.Article

Depressive Mood Changes and Psychiatric Symptoms During 12-month Low-dose Interferon-α Treatment in Patients With Malignant Melanoma Results From the Multicenter DeCOG TrialHEINZE, Sarah; EGBERTS, Friederike; BROCKMEYER, Norbert H et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 106-114, issn 1524-9557, 9 p.Article

Interferon alpha (IFNα) and psychiatric syndromes: A reviewSCHAEFER, Martin; ENGELBRECHT, Marc A; GUT, Oliver et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 4, pp 731-746, issn 0278-5846Article

Efficacy and Safety of Levetiracetam for the Prevention of Alcohol Relapse in Recently Detoxified Alcohol-Dependent Patients: A Randomized TrialRICHTER, Christoph; EFFENBERGER, Susanne; SCHAEFER, Martin et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 4, pp 558-562, issn 0271-0749, 5 p.Article

Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon-α Treatment of Patients With Malignant MelanomaFRIEBE, Astrid; HORN, Martin; SCHMIDT, Folkhart et al.Psychosomatics (Washington, DC). 2010, Vol 51, Num 6, pp 466-473, issn 0033-3182, 8 p.Article

Three Cases of Successful Tryptophan Add-On or Monotherapy of Hepatitis C and IFNα-Associated Mood DisordersSCHAEFER, Martin; WINTERER, Jochen; SARKAR, Rahul et al.Psychosomatics (Washington, DC). 2008, Vol 49, Num 5, pp 442-446, issn 0033-3182, 5 p.Article

Hepatitis C treatment in Difficult-to-treat psychiatric patients with pegylated interferon-alpha and ribavirin : Response and psychiatric side effectsSCHAEFER, Martin; HINZPETER, Axel; ZIEMER, Marlene et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 4, pp 991-998, issn 0270-9139, 8 p.Article

The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in miceORSAL, Arif Suphi; BLOIS, Sandra; LABUZ, Dominika et al.Journal of molecular medicine (Berlin. Print). 2006, Vol 84, Num 2, pp 159-167, issn 0946-2716, 9 p.Article

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject DrugsROBAEYS, Geert; GREBELY, Jason; WEDEMEYER, Heiner et al.Clinical infectious diseases. 2013, Vol 57, issn 1058-4838, S129-S137, SUP2Article

Escitalopram for the Prevention of Peginterferon-α2a―Associated Depression in Hepatitis C Virus―Infected Patients Without Previous Psychiatric DiseaseSCHAEFER, Martin; SARKAR, Rahul; OCKENGA, Johann et al.Annals of internal medicine. 2012, Vol 157, Num 2, pp 94-103, issn 0003-4819, 10 p.Article

Trajectories of Agouti-Related Protein and Leptin Levels During Antipsychotic-Associated Weight Gain in Patients With SchizophreniaEHRLICH, Stefan; LEOPOLD, Karolina; MERLE, Julia V et al.Journal of clinical psychopharmacology. 2012, Vol 32, Num 6, pp 767-772, issn 0271-0749, 6 p.Article

Health-related Quality of Life Before and During Adjuvant Interferon-α Treatment for Patients With Malignant Melanoma (DeCOG-Trial)ZIEFLE, Susanne; EGBERTS, Friederike; EIGENTLER, Thomas et al.Journal of immunotherapy (1997). 2011, Vol 34, Num 4, pp 403-408, issn 1524-9557, 6 p.Article

Tissue-specific subnetworks and characteristics of publicly available human protein interaction databasesLOPES, Tiago J. S; SCHAEFER, Martin; SHOEMAKER, Jason et al.Bioinformatics (Oxford. Print). 2011, Vol 27, Num 17, pp 2414-2421, issn 1367-4803, 8 p.Article

Levetiracetam for the Treatment of Alcohol Withdrawal Syndrome: A Multicenter, Prospective, Randomized, Placebo-Controlled TrialRICHTER, Christoph; HINZPETER, Axel; SCHMIDT, Folkhard et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 6, pp 720-725, issn 0271-0749, 6 p.Article

Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisBRUNKHORST, Frank M; ENGEL, Christoph; OLTHOFF, Derk et al.The New England journal of medicine. 2008, Vol 358, Num 2, pp 125-139, issn 0028-4793, 15 p.Article

Pretreatment levels of sTNF-R1 and sll-6R are associated with a higher vulnerability for IFN-α-induced depressive symptoms in patients with malignant melanomaFRIEBE, Astrid; SCHWARZ, Markus J; SCHMID-WENDTNER, Monika et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 3, pp 333-337, issn 1524-9557, 5 p.Article

Prolonged generalized dystonia after chronic cerebellar application of kainic acidALVAREZ-FISCHER, Daniel; GRUNDMANN, Michael; LIXIA LU et al.Brain research. 2012, Vol 1464, pp 82-88, issn 0006-8993, 7 p.Article